Aging Innovation Fund

Investing in the Future of Aging

We bring capital, healthcare expertise, industry access, and an active innovation pipeline to help promising companies move from commercial traction to market leadership.

The aging of the global population is one of the defining healthcare challenges of our time, and one of the most significant opportunities for innovation and investment. As the number of older adults grows, so too does the demand for healthcare, caregiving, technology, services, and infrastructure.

At Health Innovation Alliance, we believe the answer requires more than capital alone. It requires a deeper understanding of the challenges facing healthcare organizations, access to decision-makers across the care continuum, and the ability to identify technologies that can solve meaningful problems.

The Aging Innovation Fund was created to bring these capabilities together by investing in technology-oriented companies that address complex challenges across healthcare and aging. We are particularly interested in innovations that can improve care delivery, support older adults and caregivers, and meet the evolving needs of an aging population. We welcome companies developing meaningful solutions across healthcare, aging, care delivery, and related markets—even when an innovation does not fit neatly within a specific focus area.

A Strategic Approach to Aging Innovation

As General Partner, Health Innovation Alliance brings a unique combination of healthcare expertise, industry relationships, innovation discovery, and access to organizations actively
seeking solutions to real-world challenges.

Our approach is designed to identify companies that have moved beyond early proof of concept and are demonstrating meaningful commercial traction, while still having significant opportunity for growth.

We seek companies where technology, healthcare expertise, and market opportunity intersect—and where our network can provide more than capital.

OUR INVESTMENT PROFILE
Decorative Divider
locked documents icon

$1–3 Million Equity Checks

We generally target investments in the range of $1.0 million to $3.0 million, with the flexibility to consider structures such as preferred equity and convertible notes.

locked documents icon

Commercial-Stage Companies

We focus on companies that have established products, demonstrated market demand, and strong management teams in place.

locked documents icon

Minimum $1 Million Revenue Run Rate

Companies should generally have a minimum revenue run rate of $1 million, with a target of approximately 30–50% year-over-year growth.

locked documents icon

Technology-Oriented Businesses

Our primary focus is on technology-oriented companies operating across healthcare services, healthcare technology, care delivery, and related markets.

locked documents icon

Late Seed Through Series B

We primarily consider companies in the Late Seed through Series B stages where additional capital, strategic relationships, and market access can accelerate growth.

locked documents icon

Large and Growing Markets

We look for businesses operating in markets with strong secular tailwinds and the potential to support significant enterprise value creation, including a path toward approximately $100 million or more in enterprise value.

locked documents icon

Focused Market Leadership

We favor companies that have established or can establish market leadership within a defined, high-value niche, rather than businesses attempting to address an overly broad market without a clear competitive position.

locked documents icon

Strong Management Teams

We invest behind experienced, capable leadership teams with the vision and operational discipline to scale their businesses.

locked documents icon

Long-Term Investment Horizon

We take a long-term view, generally anticipating a 5–7 year investment horizon as companies scale, expand their markets, and create sustainable enterprise value.

Investment criteria are intended to provide general guidance and may evolve based on market conditions, fund strategy, and individual investment opportunities. All investments involve risk, and there is no guarantee that any investment will achieve its objectives or that the fund will realize returns.
LHCC AIF has been an instrumental and tremendous partner to our business. What sets them apart is their strategic approach to investing and the depth of their relationships with large strategic organizations. They don’t just make introductions—they do the hard work of helping companies like ours navigate the often-challenging waters of working with strategic partners. They approach those relationships thoughtfully, in a way that creates value for both our business and the strategic partner, while building credibility and trust along the way. The strategic lift LHCC AIF has provided to our business has been incredible. They have been much more than an investor—they have been a true strategic partner and an important part of helping us grow and navigate opportunities with some of the largest organizations in healthcare.”
Karl Ulfers - CEO & Founder | DUOS
When you talk about strategic investment, LHCC AIF is a big part of the reason I’m standing here today. They don’t just invest capital—they invest in the people and companies they believe in. They’re not afraid to make a call, make an introduction, or open a door, and they’re always there cheering you on. That kind of partnership is incredibly valuable to a growing company, and it’s what makes LHCC AIF more than just an investor—it makes them a true partner.
Alli Truttmann, MA, CPT - CEO & Founder | Wicked Technologies
MORE THAN CAPITAL

Our Fund's Key Differentiator: The Health Innovation Alliance Strategic Platform

As an organization that convenes healthcare leaders, identifies emerging technologies, and connects innovators with healthcare organizations, HIA has a direct view into the challenges health systems are trying to solve.

This creates an opportunity to support portfolio companies beyond the traditional investor relationship.

THE INNOVATION PIPELINE

Industry Access

Our network connects portfolio companies with healthcare executives, operators, innovators, and decision-makers across the healthcare ecosystem.

Executive-Led Discovery

Through HIA’s innovation pipeline, healthcare leaders help identify real-world challenges and evaluate technologies capable of addressing them.

Strategic Introductions

Our network can help facilitate introductions between companies and healthcare organizations that may serve as customers, partners, or strategic collaborators.

Data and Market Insight

Our innovation platform helps surface market needs, validate problems, and better understand where emerging technologies may have the greatest potential for impact.

Are You Building the Future of Aging?

Do you have an innovative technology or business focused on improving the way we age, deliver care, or support older adults and their caregivers?

If your company aligns with the investment criteria outlined above and you believe your solution has the potential to make a meaningful impact in the aging and healthcare ecosystem, we invite you to introduce your company to the Aging Innovation Fund.

Submission of an application does not guarantee consideration for investment or constitute an offer to invest. All submissions are subject to the fund’s investment strategy, diligence process, and applicable investment criteria.